Shanghai RAAS Blood Products Co Ltd
SZSE:002252
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Shanghai RAAS Blood Products Co Ltd
SZSE:002252
|
CN |
|
T
|
Talkmed Group Ltd
SGX:5G3
|
SG |
|
Ceres Global Ag Corp
TSX:CRP
|
US |
|
Techno Mathematical Co Ltd
TSE:3787
|
JP |
|
Aeon Co Ltd
TSE:8267
|
JP |
|
Bollore SE
OTC:BOIVF
|
FR |
|
Purple Biotech Ltd
NASDAQ:PPBT
|
IL |
|
Amuse Inc
TSE:4301
|
JP |
|
M
|
Mediclin AG
F:MED
|
DE |
|
Synlab AG
XETRA:SYAB
|
DE |
|
I
|
IG Group Holdings PLC
OTC:IGGRF
|
UK |
|
ZTO Express (Cayman) Inc
HKEX:2057
|
CN |
Bankruptcy Probability
Shanghai RAAS Blood Products Co Ltd's probability of bankruptcy is hidden . The solvency score is hidden .
We take all the information about a company's solvency (such as how easily a company can pay interest on its outstanding debt, how much cash it has, the amount of debt, and more) and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Shanghai RAAS Blood Products Co Ltd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CN |
|
Shanghai RAAS Blood Products Co Ltd
SZSE:002252
|
38B CNY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
364.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
183.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
172.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
109.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
80.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
67.6B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
39.7B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Shanghai RAAS Blood Products Co Ltd's probability of bankruptcy is hidden .
The probability of bankruptcy is estimated using credit risk models that assess its financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Shanghai RAAS Blood Products Co Ltd has total debt of 3.8B CNY. This includes both short-term (1.3B CNY) and long-term (2.5B CNY) debt.
You can find a full breakdown on its Balance Sheet.
